Insights On Drug Development

  1. Applying Next Generation Sequencing To Accelerate CGT Product Development 2/11/2025

    Next Generation Sequencing (NGS) revolutionizes gene therapy by enhancing the development and safety of viral vectors like AAV and lentivirus. Discover more about its impact.

  2. Integrating Analytical Method Development And Quality Control 2/11/2025

    As cell and gene therapies continue to advance, a well-integrated analytical framework will be critical for accelerating development timelines and optimizing regulatory submissions.

  3. Innovative RNA Manufacturing: Breaking Barriers With Mutant T7 Polymerase 2/11/2025

    Discover how advanced mRNA manufacturing innovations, including optimized RNA synthesis and scalable LNP encapsulation, are accelerating therapeutic development.

  4. CMC And Clinical Strategies For Developing Injectable, Oral Peptide Drugs 2/6/2025

    In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.

  5. World Class Quality Standards, Regulatory Expertise For Biologics Development 2/6/2025

    From early development to commercialization, SGS provides comprehensive support in meeting regulatory expectations for characterization, potency, stability, and safety testing.

  6. Specialized Scientific Expertise In Biologics From 2 Centers Of Excellence In The US, Canada 2/6/2025

    Learn about SGS’s state-of-the-art the instrumentation, technology and scientific expertise to support all aspects of biologics testing across all modalities.

  7. Explore SGS's Comprehensive Biologics Testing Capabilities 2/6/2025

    Learn about SGS’s comprehensive Biologics Testing capabilities across two centers of excellence in the U.S. and Canada.

  8. Webinar Teaser: LBA Vs. LC-MS 2/6/2025

    Why are so many sponsors shifting from Ligand-Binding Assays (LBA) to Liquid Chromatography-Mass Spectrometry (LC-MS) for large molecule protein analysis?

  9. LBA Vs. LC-MS: Competing Technologies At A Development Crossroad 2/6/2025

    Watch as bioanalytical experts Shane Karnik, MS, and Matt Hartle, Ph.D., explore why many sponsors are reevaluating the use of LBA for large molecule protein analysis in favor of LC-MS.

  10. Comparing Synthesis Processes To Establish rAAV Batch Quality 2/5/2025

    In this study, we present a comprehensive analysis of various published and newly developed dsDNA conversion processes that were tested using the same sequencing chemistry.